Alina M. Hartmann

Kiel, SH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Pegtarazimod limits acute graft-versus-host disease mortality and severity in mice and is tolerated in patients.

Pegtarazimod limits acute graft-versus-host disease mortality and severity in mice and is tolerated in patients.

Journal: The Journal of clinical investigation

Published: August 04, 2026

Radiological differentiation of original and generic dental implants using a multiclass AI model in comparison with human expertise: an in vitro study.

Radiological differentiation of original and generic dental implants using a multiclass AI model in comparison with human expertise: an in vitro study.

Journal: Journal of dentistry

Published: April 22, 2026

CD20 expression dynamics in adult B-cell acute lymphoblastic leukemia and impact on anti-CD20 treatment.

CD20 expression dynamics in adult B-cell acute lymphoblastic leukemia and impact on anti-CD20 treatment.

Journal: Journal of hematology & oncology

Published: March 31, 2026

Menin-MLL inhibitors enhance JUND activity in MLLr leukemic cells contributing to tumorigenesis and therapy resistance.

Menin-MLL inhibitors enhance JUND activity in MLLr leukemic cells contributing to tumorigenesis and therapy resistance.

Journal: Blood

Published: November 07, 2025

KMT2A-rearranged B-lymphoblastic lymphomas are skewed towards a more mature developmental stage.

KMT2A-rearranged B-lymphoblastic lymphomas are skewed towards a more mature developmental stage.

Journal: Leukemia

Published: October 22, 2025

IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALL.

IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALL.

Journal: HemaSphere

Published: September 30, 2025

Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference.

Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference.

Journal: Blood neoplasia

Published: September 24, 2025

Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemia.

Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemia.

Journal: Blood cancer journal

Published: September 19, 2025

IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

Journal: Blood

Published: August 14, 2025

Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups.

Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups.

Journal: HemaSphere

Published: August 14, 2025

IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

Journal: Blood

Published: August 14, 2025

Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Journal: Blood

Published: August 01, 2025

Showing 1-12 of 28

Last Updated: 09/26/2026